Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.20 | €11.00 | 52.863% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €3.16 | €5.58 | 76.449% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.23 | €40.66 | 55.041% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.60 | €20.43 | 76.142% |
| Immunic Inc. | 6 | 3 | 0 | 2 | €1.19 | €5.48 | 361.431% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.15 | €8.75 | 7.362% |
| Exact Sciences | 13 | 0 | 2 | 0 | €49.91 | €82.63 | 65.560% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €368.60 | €421.61 | 14.380% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €18.79 | - | - |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.80 | €21.00 | 77.997% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €9.91 | €22.78 | 129.775% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.40 | €3.25 | 132.329% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €24.00 | €68.78 | 186.580% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 18 | 0 | 3 | 0 | €249.20 | €288.66 | 15.835% |
| Incyte Corp. | 12 | 2 | 3 | 0 | €52.74 | €78.42 | 48.696% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.21 | €19.86 | 220.143% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 5 | 0 | €910.40 | €959.41 | 5.384% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 145.901% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.90 | €30.00 | 101.342% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |